Line 2: |
Line 2: |
| | | |
| ==Introduction== | | ==Introduction== |
− | PPID is a slowly-progressive disorder of the horse with a characteristic clinical picture. It is associated with '''functional adenomas''' or '''adenomatous hyperplasia of the pars intermedia of the pituitary gland'''. | + | PPID is a slowly-progressive disorder of the horse with a characteristic clinical picture. It is associated with '''functional adenomas''' or '''adenomatous hyperplasia of the pars intermedia of the [[Pituitary Gland - Anatomy & Physiology|pituitary gland]]'''. |
| | | |
| It affects all breeds of horses but is more common in '''ponies''' and Morgans. It occurs in '''older horses, between 10 and 30 years with a mean of 20 years'''. There are no sex predilections. | | It affects all breeds of horses but is more common in '''ponies''' and Morgans. It occurs in '''older horses, between 10 and 30 years with a mean of 20 years'''. There are no sex predilections. |
Line 16: |
Line 16: |
| '''Presenting signs include''': '''weight loss or muscle wasting''', decreased muscle tone, abnormal bulging of supraorbital fat pads: catabolism promoted | | '''Presenting signs include''': '''weight loss or muscle wasting''', decreased muscle tone, abnormal bulging of supraorbital fat pads: catabolism promoted |
| | | |
− | A '''thick, long and wavy hair coat''' with an abnormal shedding pattern is evident in 85% of affected horses. This sign is often preceeded by months to years of subtle coat variations, such as patchy slow shedding during late spring or delayed shedding with alopecia. | + | A '''thick, long and wavy hair coat''' with an abnormal shedding pattern is evident in 85% of affected horses. This sign is often preceded by months to years of subtle coat variations, such as patchy slow shedding during late spring or delayed shedding with alopecia. |
| | | |
− | '''Polyuria and polydipsia''': insulin antagonism, hyperglycaemia and osmotic diuresis, and ADH antagonism | + | '''Polyuria and polydipsia''': due to insulin antagonism, hyperglycaemia and osmotic diuresis, and [[Pituitary Gland - Anatomy & Physiology#Antidiuretic Hormone|ADH]] antagonism |
| | | |
| '''Lethargy''' | | '''Lethargy''' |
Line 24: |
Line 24: |
| '''Persistent sweating''' | | '''Persistent sweating''' |
| | | |
− | '''Chronic recurrent laminitis''': digital vasoconstrictive effects of catecholamines | + | '''Chronic recurrent [[Laminitis - Horse|laminitis]]''': due to digital vasoconstrictive effects of catecholamines |
| | | |
− | '''Chronic recurrent skin, pulmonary, urinary, or sinus infections''': immunosuppression | + | '''Chronic recurrent skin, pulmonary, urinary, or sinus infections''': due to immunosuppression |
| | | |
| '''Vision disturbances''': central effects | | '''Vision disturbances''': central effects |
| | | |
| ==Diagnosis== | | ==Diagnosis== |
− | '''Plasma cortisol concentration''': there is a wide variation in normal values and it is not useful in diagnosing the condition. | + | '''Plasma cortisol concentration''' can be measures but there is a wide variation in normal values and it is not useful in diagnosing the condition. |
| | | |
| '''The dexamethasone suppression test''' is the gold standard for diagnosis of the disease. Plasma cortisol samples are taken before and after dexamethasone administration. Normal horses will show a level of cortisol below 1 μg/dL 19 hours after dexamethasone administration, whereas affected horses will show a small degree of suppression in cortisol levels, but not to the level of normal horses, and levels also rebound more quickly. | | '''The dexamethasone suppression test''' is the gold standard for diagnosis of the disease. Plasma cortisol samples are taken before and after dexamethasone administration. Normal horses will show a level of cortisol below 1 μg/dL 19 hours after dexamethasone administration, whereas affected horses will show a small degree of suppression in cortisol levels, but not to the level of normal horses, and levels also rebound more quickly. |
| | | |
| A variety of other tests exist to evaluate horses for PPID: | | A variety of other tests exist to evaluate horses for PPID: |
− | | + | :'''ACTH stimulation test, resting ACTH level, TRH stimulation test, glucose tolerance test, insulin levels and insulin tolerance test''' |
− | '''ACTH stimulation test, resting ACTH level, TRH stimulation test, glucose tolerance test, insulin levels and insulin tolerance test''' | |
| | | |
| None of these are of greater sensitivity or specificity than the dexamethasone suppression test and are frequently less convenient to perform and more expensive. | | None of these are of greater sensitivity or specificity than the dexamethasone suppression test and are frequently less convenient to perform and more expensive. |
| | | |
− | The only disadvantage of the dexamethasone suppression test is the reported increased risk of laminitis. | + | The only disadvantage of the dexamethasone suppression test is the reported increased risk of laminitis. In at risk cases, '''ACTH levels''' are nearly as sensitive in diagnosing the condition. |
− | | |
− | In at risk cases, '''ACTH levels''' are nearly as sensitive in diagnosing the condition. | |
− | | |
| | | |
− | '''Haematology and biochemistry''' may reveal: hyperglycaemia and hyperlipidaemia. Liver enzymes may be elevated due to hepatic lipidosis secondary to the lipolysis. There may be a stress leukogram. | + | '''Haematology and biochemistry''' may reveal hyperglycaemia and hyperlipidaemia. Liver enzymes may be elevated due to [[Hepatic Lipidosis|hepatic lipidosis]] secondary to the lipolysis. There may be a [[Stress Leucogram|stress leukogram]]. |
| | | |
| | | |
Line 52: |
Line 48: |
| | | |
| ==Treatment== | | ==Treatment== |
− | Treatment can be difficult due to the age of the animal and the multiple problems which can occur in a given animal. | + | Treatment can be difficult due to the age of the animal and the multiple problems which can occur in a given individual. |
| | | |
| In some animals, there may be '''unacceptable pain''' from laminitis, or marked debilitation from the muscle wasting and '''euthanasia''' may be the humane decision. | | In some animals, there may be '''unacceptable pain''' from laminitis, or marked debilitation from the muscle wasting and '''euthanasia''' may be the humane decision. |
| | | |
| Other cases may be managed by '''supportive therapy''': | | Other cases may be managed by '''supportive therapy''': |
− | :Treating any '''infections''': skin and respiratory | + | :Treating any '''infections''' (skin and respiratory) |
| :Maintaining a '''high plane of nutrition''' | | :Maintaining a '''high plane of nutrition''' |
− | :Hoof care for mild laminitis, or '''NSAIDs''' if needed | + | :Hoof care for mild laminitis, or '''[[NSAIDs]]''' if needed |
| :'''Clipping''' to remove long hair | | :'''Clipping''' to remove long hair |
| These cases may have an acceptable quality of life for several years. | | These cases may have an acceptable quality of life for several years. |
Line 66: |
Line 62: |
| :'''Cyproheptadine''': a serotonin antagonist, was one of the first drugs used for the disease. The response is variable | | :'''Cyproheptadine''': a serotonin antagonist, was one of the first drugs used for the disease. The response is variable |
| :'''Bromocriptine''': dopaminergic agonist, to replace loss of dopaminergic innervation. The bioavailability of the drug is low. | | :'''Bromocriptine''': dopaminergic agonist, to replace loss of dopaminergic innervation. The bioavailability of the drug is low. |
− | :'''Pergolide''': dopaminergic agonist, therapy of choice. Clinical improvement occurs in a few weeks in approximately 80% of cases. Doses can be increased if signs are still apparent, but treatment should be stopped if diarrhoea, anorexia and worsening laminitis occur. | + | :'''Pergolide''': dopaminergic agonist, '''therapy of choice'''. Clinical improvement occurs in a few weeks in approximately 80% of cases. Doses can be increased if signs are still apparent, but treatment should be stopped if diarrhoea, anorexia and worsening laminitis occur. |
− | :'''Trilostane''': inhibits 3-beta-hydroxysteroid dehydrogenase. Used in Canine Cushing's, but variable results in horses. | + | :'''Trilostane''': inhibits 3-beta-hydroxysteroid dehydrogenase. It is used in [[Hyperadrenocorticism|Canine Cushing's]] but gives variable results in horses. |
| | | |
| ==Prognosis== | | ==Prognosis== |
Line 90: |
Line 86: |
| | | |
| | | |
− | [[Category:To Do - Helen]] | + | {{review}} |
− | [[Category:To Do - Review]] | + | [[Category:Endocrine Diseases - Horse]] |
| + | [[Category:Expert Review - Horse]] |